Psychological Impact of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation on Donors
Recruiting
N/A
Interventional Study
Haplo-identical Transplantation
Transplantation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 50 (estimated)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Allogeneic hematopoietic stem cell transplantation (allo-HSC) is currently one of the only curative treatments for haematological malignancies with a poor prognosis, the realization of which presupposes the identification and availability of a compatible donor. In recent years, haploidentical transplants have been developed, a reliable alternative for patients who do not have 100% compatible donor…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria:
* Identical haplo CSH donors ascending (parents) or descending (children)
* Major identical haplo HSC donors
* Haplo-identical HSC donors living in mainland France and cared for in the centers participating in the study
* Haplo-identical HSC donors benefiting from Social Securit…
Contacts